NCT07049341 · ENROLLING BY INVITATION
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
This pilot study asks people with neurological diseases, and their caregivers, how it feels to use the MemorEM, a head-worn device, over a long period. The main goal is feedback on comfort and design, not whether it works. It is an early, small study with no phase, so nothing here is proven or approved.
You may qualify if
- Patient diagnosed with a neurological disease involving aggregated proteins such as Alzheimer's and its variants, Parkinson's, Frontotemporal dementia, Amyotrophic lateral sclerosis, Tauopathies, and other related neurological diseases.
- Presence of a caregiver(s) responsible for ensuring treatment compliance and potentially with authority to make medical decisions for the patient if the patient is not competent to make those decisions
- Willing to sign NeuroEM's patient consent form
You're excluded if
- Patient has uncontrolled: Seizures, Epilepsy, Depression, Bipolar disorder, psychotic disorders, alcoholism or drug addiction
- Presence of metal implants in the head, except for metal dental implants
- Patient has hypertension that is unresponsive to anti-hypertensive medications
- Patient has implanted medication pumps unless cleared by physician
- Patient has significant heart disease, as determined by a physician
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-08-05